Dr Carla Startin

Teaching Fellow

Academic and research departments

School of Psychology.


Research interests



Startin CM, Lowe B, Hamburg S, Hithersay R, Strydom A (accepted). Validating the Cognitive Scale for Down Syndrome (CS-DS) to detect longitudinal cognitive decline in adults with Down syndrome. Front Psychiatry. DOI 10.3389/fpsyt.2019.00158

Startin CM, Ashton NJ, Hamburg S, Hithersay R, Wiseman FK, Mok KY, Hardy J, Lleo A, Lovestone S, Parnetti L, Zetterberg H, Hye A, Strydom A (accepted). Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease. Alzheimer's Res Ther

Hamburg S, Rosch R, Startin CM, Friston KJ, Strydom A (accepted). Dynamic causal modelling of the relationship between cognition and theta-alpha oscillations in adults with Down syndrome. Cereb Cortex

Startin CM, Hamburg S, Strydom A (2019). Comparison of receptive verbal abilities assessed using the KBIT-2 and BPVS3 in adults with Down syndrome. Front Psychol 9: 2730. DOI 10.3389/fpsyg.2018.02730

Hithersay R, Startin CM, Hamburg S, Mok KY, Hardy J, Fisher EMC, Tybulewicz VLJ, Nizetic D, Strydom A (in press). Association of dementia with mortality among adults with Down syndrome older than 35 years. JAMA Neurol DOI: 10.1001/jamaneurol.2018.3616

Startin CM, Hamburg S, Hithersay R, Al-Janabi T, Mok KY, Hardy J, Strydom A (2019). Cognitive markers of preclinical and prodromal Alzheimer’s disease in Down syndrome. Alzheimers Dement 15(2): 245-257. DOI: 10.1016/j.jalz.2018.08.009

Firth NC, Startin CM, Hithersay R, Hamburg S, Wijeratne PA, Mok KY, Hardy J, Alexander DC, Strydom A (2018). Aging related cognitive changes associated with Alzheimer's disease in Down syndrome. Ann Clin Transl Neurol 5(6): 741-751. DOI: 10.1002/acn3.571

Strydom A, Heslegrave A, Startin CM, Mok KY, Hardy J, Groet J, Nizetic D, Zetterberg H (2018). Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome. Alzheimer's Res Ther 10: 39. DOI: 10.1186/s13195-018-0367-x

Hamburg S, Startin CM, Strydom A (2017). The relationship between sound-shape matching and cognitive ability in adults with Down syndrome. Multisens Res 30(6): 537-547. DOI: 10.1163/22134808-00002579

Startin CM, Hamburg S, Hithersay R, Davies A, Rodger E, Aggarwal N, Al-Janabi T, Strydom A (2016). The LonDownS adult cognitive assessment to study cognitive abilities and decline in Down syndrome. Wellcome Open Res 1: 11. DOI: 10.12688/wellcomeopenres.9961.1

Startin CM, Rodger E, Fodor-Wynne L, Hamburg S, Strydom A (2016). Developing an informant questionnaire for cognitive abilities in Down syndrome: the Cognitive Scale for Down Syndrome (CS-DS). PLoS ONE 11(5): e0154596. DOI: 10.1371/journal.pone.0154596

Karmiloff-Smith A, Al-Janabi T, D'Souza H, Groet J, Massand E, Mok K, Startin C, Fisher E, Hardy J, Nizetic D, Tybulewicz V, Strydom A (2016). The importance of understanding individual differences in Down syndrome. F1000Res 5(F1000 Faculty Rev): 389. DOI: 10.12688/f1000research.7506.1

Startin CM, Fiorentini C, de Haan M, Skuse DH (2015). Variation in the X-linked EFHC2 gene is associated with social cognitive abilities in males. PLoS ONE 10(6): e0131604. DOI: 10.1371/journal.pone.0131604

Lyons L, Elbeltagy M, Umka J, Markwick R, Startin C, Bennett G, Wigmore P (2011). Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy. Psychopharmacology 215(1): 105-115. DOI: 10.1007/s00213-010-2122-2

de Medeiros MA, Startin CM, Jeffery ND (2009). Innervation of canine skin: an immunohistochemical study. Vet Rec 165: 314-318. DOI: 10.1136/vr.165.11.314